Dubai [UAE], February 26 (ANI/WAM): The second edition of the Dubai Stem Cell Congress (DSCC) kicks off today at Palazzo Versace in Dubai.
Its current edition brings together more than 30 experts and specialists in stem cell treatment from Japan, the USA, Sweden, Finland, Germany, the Netherlands, Qatar, and the UAE.
The congress holds exceptional significance as it introduces a new theme, "Connecting Hope". This innovative platform establishes connections between scientists and patients, serving as the cornerstone for the annual congress.
The congress presents different awards such as the "Humanitarian Award," the Prestigious Award, the "Champions Award" for Best Contribution, "The Great Initiative Mind," Unique Initiative, and "Academic ACE": Best Student, "Ingenious Thinker," and Best Researcher.
This year's congress introduces the prestigious Humanitarian Award, honouring the legacy of Dr. Hal Broxmeyer. His groundbreaking contributions revolutionised regenerative medicine, benefitting over 50,000 patients globally with cord blood stem cell therapies. This award is to be accepted by his wife, Beth Broxmeyer, symbolizing his enduring impact on the field.
"The Great Initiative Mind" aims to acknowledge and inspire the outstanding contributions of scientists and researchers in bringing cutting-edge technologies to the field of stem cells and regenerative medicine in the UAE. The esteemed scientific committee, comprising luminaries and thought leaders from across the globe, ensures that the congress remains at the forefront of sc."ientific inquiry and technological innovation.
This year's edition endeavours to elevate the dialogue with a dynamic lineup of more than 30 notable speakers renowned globally for their expertise in the stem cell industry, with over 18 speakers hailing from the US, ensuring a diverse and enriching exchange of insights and innovations. Prominent luminaries such as Dr. Jacques Galipeau, MD, a distinguished medical professional specializing in internal medicine and oncology, are the Don and Marilyn Anderson, Tenured Professor of Oncology at the University of Wisconsin, showcases leadership in therapeutic development.
Dr. Fatma Alhashimi, Chairman of the DSCC and Director of Hortman Stem Cell Laboratory, stated, "Today, the Dubai Stem Cell Congress convenes with international experts and industry partners, uniting to raise awareness and highlight the latest advancements in data, stem cell technologies, and innovative applications. The congress offers a comprehensive platform for exploring cutting-edge topics in stem cell research.
"Sessions cover a wide array of themes, including stem cells and regenerative medicine, stem cells' role in cardiovascular diseases, uncovering insights from stem cell research, and advancements in stem technologies and gene therapies. Through these sessions, researchers and experts delve into the latest discoveries, techniques, and applications, fostering collaboration and innovation in the dynamic fields of stem cell science and regenerative medicine," she said.
Dr. Alhashimi emphasised the importance of raising awareness among community members about the significance of preserving their own stem cell samples or opting to donate them to others. This contribution is instrumental in the treatment of various blood-related diseases, cancers, and immunity disorders, offering individuals the chance for complete recovery from these ailments.
Another viable option that Dr. Alhashimi highlighted involves encouraging individuals to participate in stem cell research initiatives aimed at advancing medical knowledge and developing innovative treatments for a wide range of health conditions.
She added, "Today, through the opening ceremony, we reviewed the highlights of the success stories of many cases that received cord therapy and reviewed the importance of donating cords to those who do not want to keep it to enable the largest number of patients in the world to have a new lease of life."
The congress addressed several incurable diseases, such as thalassemia, hereditary Fanconi anaemia leading to aplastic anaemia, and leukaemia. The UAE stands out as a country witnessing a significant number of individuals affected by thalassemia due to factors like consanguineous marriage. Hence, umbilical cord treatment emerges as a golden opportunity for patients, offering a ray of hope as some can be effectively treated using blood cells extracted from the umbilical cord. Among the heartening narratives shared at the conference, Mahra's story shone brightly, illustrating successful treatment and recovery through this innovative technique.
The congress is organised by INDEX Conferences and Exhibitions Organisation LLC, a member of INDEX Holding. Supported by the Dubai Health Authority, the two-day conference offers 13 CME points to participants. (ANI/WAM)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor